The effectiveness of chemotherapy in "real world" patients with metastatic bladder cancer

被引：2
|
作者：
Galsky, M. D. [1 ]
Pal, S. K. [2 ]
Lin, S. W. [3 ]
Ogale, S. [3 ]
Simpson, J. [3 ]
Schiff, C. [3 ]
Sonpavde, G. [4 ]
机构：
[1] Mt Sinai Hosp, Icahn Sch Med, New York, NY 10029 USA
[2] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31442-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2624
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 50 条
  • [31] Effectiveness of a program of early instillation single chemotherapy in patients with bladder cancer
    Villar, P. Beardo
    Perez, A. B. Perez
    Dorantes, M. J. Castro
    Delgado, S. J. Jimenez
    Ortega, P. Alamillos
    Moreno, R. Gavira
    REVISTA DE CALIDAD ASISTENCIAL, 2016, 31 (04) : 234 - 238
  • [32] Chemotherapy in locally advanced and metastatic bladder cancer
    Kuczyk, MA
    Zimmermann, R
    Merseburger, A
    Anastasiadis, A
    Corvin, S
    Hartmann, JT
    Stenzl, A
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (03) : 79 - 88
  • [33] Systemic chemotherapy in inoperable or metastatic bladder cancer
    Bamias, A
    Tiliakos, I
    Karali, M
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 553 - 561
  • [34] Systemic chemotherapy options for metastatic bladder cancer
    Siefker-Radtke, Arlene
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 877 - 885
  • [35] Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
    Acedo, Rocio Diaz
    Banqueri, Mercedes Galvan
    Criado, Silvia Artacho
    Parra, Eva Maria Fernandez
    Galan, Rocio Jimenez
    Sanchez, Ana Isabel Gago
    Pozo, Juan Francisco Marin
    Bautista, Maria Jose Martinez
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 382 - 389
  • [36] Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
    Rocío Díaz Acedo
    Mercedes Galvan Banqueri
    Silvia Artacho Criado
    Eva María Fernández Parra
    Rocío Jiménez Galán
    Ana Isabel Gago Sánchez
    Juan Francisco Marín Pozo
    María José Martínez Bautista
    International Journal of Clinical Pharmacy, 2024, 46 : 382 - 389
  • [37] Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer.
    Satram-Hoang, Sacha
    Ramanan, Devi
    Lee, Luen F.
    Yu, Shui
    Reyes, Carolina M.
    McKenna, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] Real-world outcomes in patients receiving upfront docetaxel chemotherapy for metastatic castrate sensitive prostate cancer
    Wong, Jeff
    Nindra, Udit
    Balakrishnar, Bavanthi
    Della-Fiorentina, Stephen
    Adams, Diana
    Roncolato, Felicia
    Pal, Abhijit
    Chua, Wei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 102 - 102
  • [39] A real-world study of chemotherapy treatment and costs in metastatic urothelial cancer (mUC) patients in the United States
    Malangone-Monaco, Elisabetta
    Wilson, Kathleen
    Varker, Helen
    Stetsovsky, Diana
    Shih-Wen, Lin
    Tayama, Darren
    Ogale, Sarika
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Effectiveness of adjuvant chemotherapy for invasive bladder cancer
    Araujo, A.
    Savva-Bordalo, J.
    Ferreira, M.
    Sousa, N.
    Mauricio, J.
    Begonha, R.
    Pinto, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 449 - 449
12345